John is currently Chairman of the Board of Directors and served as the founding president, chief executive officer and a member of the board of directors at T2 Biosystems from 2007 through January 2020.
Responsible for raising over $500 million of public and private capital creating over $6 billion of market value for 5 different companies over the past 30 years. Currently Chairman of the Board of Directors at T2 Biosystems and Cytrellis Biosystems and Board Director at Solace Therapeutics.
John previously served in CEO and senior executive management roles in both private and public companies - successfully led 2 IPO's, was CEO of 4 companies including 2 established public companies, was CEO or senior management executive at 4 start up companies, led the acquisition of 5 companies, led merger or acquisition of business with 3 different companies and was Board member of 2 companies successfully acquired by industry leaders.
